| Time | Workshop Room 1 | Workshop Room 2 |
| 08.00 - 15.00 | Workshop Of Hypertension Management | Workshop Of Hypertension Bb Omron Academy |
| Interactive Case Discussion | Interactive Case Discussion | |
| 16.00 - 18.00 | BUSINESS MEETING - INASH |
| Time | Ballroom 1 | Ballroom 2 | Ballroom 3 | |
| 08.00 - 08.30 | MORNING TALKS ON HYPERTENSION | |||
| 08.30 - 09.30 | PLENARY SESSION 1 | |||
| 09.30 - 10.00 | OPENING CEREMONY | |||
| 10.00 - 10.30 | COFFEE BREAK | |||
| 10.30 - 11.30 | YOUNG INVESTIGATOR AWARD | Symposium 1 Supported by Zuellig Pharma Protecting the Cardio-Kidney-Metabolic Universe: Guardiance of the Galaxy |
Symposium 2 Partial Symposium by Dexa Medica & Ferron Primary Hypertension Mediated Organ Damage Prevention |
MODERATED POSTER 1 (MP Corner) |
| 11.30 - 12.30 | Lunch Symposium 1 Supported by Servier Silent Risks, Loud Warnings: Navigating the Dual Burden of Hypertension and Diabetes |
Lunch Symposium 2 Supported by Astra Zeneca Guideline Directed Medical Treatment of Heart Failure |
||
| 12.30 - 13.30 | LUNCH | |||
| 13.30 - 14.30 | Trigger Quiz (Preliminary Round) |
Symposium 3 Partial Symposium by Merck & Prodia Future Cardiovascular Care: Metabolism, Screening and Therapy |
Symposium 4 Partial Symposium by Darya Varia & Aurogen New Approaches In The Management of Hypertension |
MODERATED POSTER 2 (MP Corner) |
| 14.30 - 15.30 | Symposium 5 ASCVD and Secondary Hypertension: When to Aware, How to Manage |
Symposium 6 Overly-Treated Hypertension: Is It Risk-Free? |
||
| 15.30 - 15.45 | Wrap Up | |||
| 15.45 - 16.00 | Closing Day 1 | |||
| 19.00 - 20.00 | Dinner Symposium Supported by Kalbe Pharma Revisiting the Role of Combined Alpha-Beta-Adrenergic Antagonist in Hypertensive Emergency Management |
|||
| Time | Ballroom 1 | Ballroom 2 | Ballroom 3 | |
| 08.00 - 08.30 | DEBATE SESSION | |||
| 08.30 - 09.30 | PLENARY SESSION 2 | |||
| 09.30 - 10.00 | INASH AWARD | |||
| 10.00 - 10.30 | COFFEE BREAK | |||
| 10.30 - 11.30 | Trigger Quiz (Final Round) |
Symposium 7 Aldosterone and Hypertension |
Symposium 8 Supported by Novonordisk Semaglutide beyond the Scale: Advancing Cardiometabolic Health in Patient with Obesity |
MODERATED POSTER 1 (MP Corner) |
| 11.30 - 12.30 | Lunch Symposium 3 JOINT SYMPOSIUM WITH HOPE ASIA NETWORK |
Lunch Symposium 4 JOINT SYMPOSIUM WITH ASIAN-PACIFIC SOCIETY OF HYPERTENSION |
||
| 12.30 - 13.30 | LUNCH | |||
| 13.30 - 14.30 | Symposium 9 Detecting the Invisible: Identifying Subclinical Organ Damage of Hypertension in Community |
Symposium 10 Primordial Hypertension: Application in Society |
||
| 14.30 - 15.00 | WRAP UP | |||
| 15.00 - 15.30 | Launching InaSH Consensus | |||
| 15.30 - 16.00 | CLOSING CEREMONY | |||